A cobalt complex that selectively disrupts the structure and function of zinc fingers
- Creators
- Louie, A. Y.
- Meade, T. J.
Abstract
Zinc finger domains are structures that mediate sequence recognition for a large number of DNA-binding proteins. These domains consist of sequences of amino acids containing cysteine and histidine residues tetrahedrally coordinated to a zinc ion. In this report, we present a means to selectively inhibit a zinc finger transcription factor with cobalt(III) Schiff-base complexes. ^(1)H NMR spectroscopy confirmed that the structure of a zinc finger peptide is disrupted by axial ligation of the cobalt(III) complex to the nitrogen of the imidazole ring of a histidine residue. Fluorescence studies reveal that the zinc ion is displaced from the model zinc finger peptide in the presence of the cobalt complex. In addition, gel-shift and filter-binding assays reveal that cobalt complexes inhibit binding of a complete zinc finger protein, human transcription factor Sp1, to its consensus sequence. Finally, a DNA-coupled conjugate of the cobalt complexes selectively inhibited Sp1 in the presence of several other transcription factors.
Additional Information
© 1998 The National Academy of Sciences. Communicated by John D. Baldeschwieler, California Institute of Technology, Pasadena, CA, April 13, 1998 (received for review May 23, 1997). We thank Drs. Keiko Kato, Scott Fraser, and Harry Gray for helpful discussion and Bassil Dahiyat for assistance with the CD measurements. This work was supported by the Biological Imaging Center of the Beckman Institute and the Redox Pharmaceutical Corporation. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. §1734 solely to indicate this fact.Attached Files
Published - PNAS-1998-Louie-6663-8.pdf
Files
Name | Size | Download all |
---|---|---|
md5:9466970a54beed254ed1ce0adb8f7cc3
|
214.3 kB | Preview Download |
Additional details
- PMCID
- PMC22591
- Eprint ID
- 52165
- Resolver ID
- CaltechAUTHORS:20141125-151941705
- Caltech Beckman Institute
- Redox Pharmaceutical Corporation
- Created
-
2014-11-26Created from EPrint's datestamp field
- Updated
-
2021-11-10Created from EPrint's last_modified field